HyperClear represents an innovative laser therapy system designed to effectively remove surplus prostatic tissue in benign prostatic hyperplasia (BPH). Leveraging the LIFE (Laser-Induced Fiber Enucleation) method, HyperClear applies precise laser energy via a flexible fiber placed transurethrally to the obstructive zone, ablating the excess prostate tissue responsible for lower urinary tract symptoms (LUTS). This approach may be performed outpatient—often with local anesthesia—enhancing patient comfort while maintaining efficacy and safety.
High-Precision Laser Fiber
- Optimized Energy Delivery: The laser fiber is advanced through the urethra to the blocked area, targeting surplus prostate tissue while minimizing collateral damage.
- LIFE Method: Focused on selective tissue vaporization or enucleation, ensuring clean resection planes and predictable tissue removal.
Outpatient Feasibility
- Local Anesthesia: Allows many patients to undergo the procedure without the risks or recovery times associated with general anesthesia.
- Rapid Recovery: Less invasive than conventional transurethral resections, potentially reducing hospital stays and improving patient throughput.
Real-Time Visualization
- Precise Tissue Identification: Endoscopic imaging guides the laser fiber to the obstructive tissue, ensuring thorough clearance of the prostatic urethra.
- Controlled Ablation: The surgeon can finely tune laser energy to match the tissue’s vascularity and density, limiting the risk of deep thermal damage.
Efficient & Gentle Tissue Removal
- Targeted Laser Ablation: Precisely removes hyperplastic prostate segments that hinder urine flow, preserving healthy tissue zones.
- Hemostatic Effect: Laser energy also cauterizes small vessels during tissue vaporization, reducing intraoperative bleeding.
臨床優勢與應用
Benign Prostatic Hyperplasia (BPH)
- Symptomatic Relief: Alleviates classic LUTS such as frequent urination, weak urine stream, and prolonged emptying times.
- Patient Selection: Suited for patients with moderate-to-severe BPH who seek a less invasive alternative to standard TURP or open prostatectomy.
Minimal Invasiveness
- Outpatient Possibility: Potentially performed under local anesthesia, minimizing hospitalization and facilitating early mobilization.
- Lower Bleeding Risk: Laser-based enucleation or vaporization significantly reduces hemorrhage compared to mechanical resection methods.
強化病患體驗
- Shorter Convalescence: Many patients resume daily activities sooner, with less postoperative discomfort or catheterization durations.
- Reduced Need for General Anesthesia: Local or spinal anesthesia lessens systemic risks, beneficial for older or comorbid patients.
Technical Specifications
| 規格 | 細節 / 價值 |
| 產品名稱 | CytroFIX® Superior Clavicula Plates |
| 材質 | High-Purity Titanium Alloy (e.g., Ti-6Al-4V ELI) |
| Plate Profile | Low-profile, contoured for superior clavicle placement |
| Locking Mechanism | Locking or non-locking titanium screws; optional variable-angle locking |
| Screw Diameter | 2.7 mm or 3.5 mm (titanium cortical screws, depending on hole specification) |
| Plate Thickness | ~2.0–2.5 mm (minimized profile) |
| Hole Array | Multiple holes for bridging, compression, or combined fixation patterns |
| 放射能力 | Titanium visible on fluoroscopy (optional etched markers) |
| 無菌 | Provided non-sterile (autoclavable) or sterile, single use or reusable instrumentation (verify product line) |
| 保質期 | Indefinite if stored properly; reusable within recommended inspection cycles |
| 臨床適應症 | Midshaft/lateral clavicle fractures requiring superior plating, osteotomies, nonunion correction |
| Regulatory Compliance | Conforms to ISO 13485, CE/FDA (region-specific), meets orthopedic implant standards |
Size & Ordering Matrix
| Plate Length (mm) | Hole Count | Curvature | Compatible Screw | 產品編號 | 注意事項 |
| 60 | 4 | Mild Superior Bend | 2.7 mm Locking/Non-Locking | CFX-SCL-60-4-27-Ti | Shorter plate for smaller fractures in lateral or mid-shaft |
| 70 | 5 | Mild Superior Bend | 2.7 mm Locking/Non-Locking | CFX-SCL-70-5-27-Ti | Extended coverage for mild to moderate fractures |
| 80 | 5 | Moderate Superior Bend | 2.7 or 3.5 mm Locking | CFX-SCL-80-5-MX-Ti | Bridges midshaft fractures with variable-angle options |
| 90 | 6 | Moderate Superior Bend | 3.5 mm Locking/Non-Locking | CFX-SCL-90-6-35-Ti | For larger or multi-fragment fractures requiring robust support |
| 100 | 7 | Enhanced Superior Contour | 3.5 mm Locking/Non-Locking | CFX-SCL-100-7-35-Ti | Accommodates more complex or extended fracture lines |
| 110 | 8 | Enhanced Superior Contour | 3.5 mm Locking/Non-Locking | CFX-SCL-110-8-35-Ti | Longest plate design for challenging multi-segment fractures |
相關商品
-

ThermoEdge RFA:多功能射頻消融平台
查看內容多功能射頻消融系統,專為精確有效地治療各種病症而設計,包括 月經過多、子宮肌瘤 (肌瘤)、 和 微創、不流血的切除手術 的 肝臟和腎臟組織, 以及囊腫治療。
-

UroGlide 輸尿管導管
查看內容這些導管專為流暢可靠的導航而設計,可確保在泌尿科手術中有效率地引流和進入,減少創傷並最佳化病患舒適度。
-

用於泌尿系統手術的 Zebra 導線
查看內容靈活、高可靠性的導覽線,專為泌尿科介入手術中的精確導航而設計,可確保加強控制、減少創傷,並為微創手術提供最佳支援。
-

HyperTiss 膀胱癌腔內低溫治療套裝
查看內容一種先進的醫療系統,設計用來直接向膀胱腔提供受控的低溫療法,藉由增加腫瘤對化療的敏感度及降低復發率,來提升膀胱癌治療的療效。
